open access

Vol 70, No 5 (2012)
Original articles
Published online: 2012-05-23
Submitted: 2012-12-28
Get Citation

Initial troponin level may predict thrombus burden in patients with acute coronary syndrome. Optical coherence tomography study

Tomasz Pawłowski, Francesco Prati, Davide Capodanno, Corado Tamburino, Robert J. Gil
Kardiol Pol 2012;70(5):457-462.

open access

Vol 70, No 5 (2012)
Original articles
Published online: 2012-05-23
Submitted: 2012-12-28

Abstract


Background: The major cause of acute coronary syndrome (ACS) is vessel thrombosis related to plaque rupture. Optical coherence tomography (OCT) is a feasible and effective technique to visualise a thrombus in vivo.
Aim: To present the relationship between cardiac enzymes leakage before coronary angioplasty and thrombus visualised by OCT.
Methods: A population of 48 consecutive patients (mean age 64.8 ± 9 years) with non ST elevation syndromes treated with primary coronary angioplasty was selected for the study. Angiographic and OCT quantitative assessment was performed for all patients, as well as qualitative thrombus assessment with a new index — the thrombus score (TS). Troponin I and creatine kinase and its MB fraction were measured for all patients at baseline and at least 6–8 hours after coronary angioplasty.
Results: The troponin level assessed before coronary angioplasty was 3.42 ± 7.31 ng/dL. The mean TS assessed before coronary angioplasty was 96 ± 56, and in 17 (35.4%) patients the score was greater than 100 points. Mean artery length occupied by thrombus was 7.8 ± 3.8 mm. There was a significant correlation between troponin level and thrombus score (r = 0.44, p < 0.05) in the whole studied population.
Conclusions: Initial troponin level may be associated with larger thrombus burden within a coronary artery. This finding may influence coronary flow and needs to taken into consideration during primary coronary intervention.

Abstract


Background: The major cause of acute coronary syndrome (ACS) is vessel thrombosis related to plaque rupture. Optical coherence tomography (OCT) is a feasible and effective technique to visualise a thrombus in vivo.
Aim: To present the relationship between cardiac enzymes leakage before coronary angioplasty and thrombus visualised by OCT.
Methods: A population of 48 consecutive patients (mean age 64.8 ± 9 years) with non ST elevation syndromes treated with primary coronary angioplasty was selected for the study. Angiographic and OCT quantitative assessment was performed for all patients, as well as qualitative thrombus assessment with a new index — the thrombus score (TS). Troponin I and creatine kinase and its MB fraction were measured for all patients at baseline and at least 6–8 hours after coronary angioplasty.
Results: The troponin level assessed before coronary angioplasty was 3.42 ± 7.31 ng/dL. The mean TS assessed before coronary angioplasty was 96 ± 56, and in 17 (35.4%) patients the score was greater than 100 points. Mean artery length occupied by thrombus was 7.8 ± 3.8 mm. There was a significant correlation between troponin level and thrombus score (r = 0.44, p < 0.05) in the whole studied population.
Conclusions: Initial troponin level may be associated with larger thrombus burden within a coronary artery. This finding may influence coronary flow and needs to taken into consideration during primary coronary intervention.
Get Citation

Keywords

acute coronary syndrome; optical coherence tomography; troponin

About this article
Title

Initial troponin level may predict thrombus burden in patients with acute coronary syndrome. Optical coherence tomography study

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 70, No 5 (2012)

Pages

457-462

Published online

2012-05-23

Bibliographic record

Kardiol Pol 2012;70(5):457-462.

Keywords

acute coronary syndrome
optical coherence tomography
troponin

Authors

Tomasz Pawłowski
Francesco Prati
Davide Capodanno
Corado Tamburino
Robert J. Gil

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl